The Lundquist Institute holds both U.S. and international patents for this humanized antibody and has granted Vitalex, a Lundquist spin-off company, the commercial rights to advance this therapeutic ...
News Medical on MSN13d
Antibody-based therapy is several steps closer to treat lethal mucormycosisAshraf Ibrahim, PhD, an investigator at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center for ...
Mucormycosis, a fungus infection caused by Mucorales, has a high mortality rates in those with weakened immune systems and ...
The infection is aggressive and considered a medical emergency that needs immediate ... Institute for Biomedical Innovation at Harbor-UCLA Medical Center The Lundquist Institute for Biomedical ...
Weʼre Not There Yet, but Weʼre Headed in the Right Direction: The Promise of AI in Clinical Medicine
He earned his medical degree from UCSF and completed his emergency medicine residency at Harbor-UCLA. An administrative fellow at Vituity, he specialized in CMS quality programs. Dr. Miller also ...
Advt Ashraf Ibrahim, PhD, an investigator at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center ... and considered a medical emergency that needs immediate attention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback